How severe is CVE-2019-13539?

CVE-2019-13539 has a CVSS 3.x base score of 7.0, rated high severity. It is exploitable over local access with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2019-13539 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (18th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2019-13539?

CVE-2019-13539 primarily affects Medtronic Valleylab Exchange Client. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2019-13539?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2019-13539 published?

CVE-2019-13539 was published on 2019-11-08 and last updated on 2026-06-17.

CVE-2019-13539

CVE-2019-13539 is a high-severity vulnerability in Medtronic Valleylab Exchange Client with a CVSS 3.x base score of 7.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-326.

Key facts

Severity: High (CVSS 3.x base score 7.0)
CVSS v2: 7.2
EPSS exploit prediction: 0% (18th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-326
Affected product: Medtronic Valleylab Exchange Client
Published: 2019-11-08
Last modified: 2026-06-17

Description

Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use the descrypt algorithm for OS password hashing. While interactive, network-based logons are disabled, and attackers can use the other vulnerabilities within this report to obtain local shell access and access these hashes.

Frequently asked questions

What is CVE-2019-13539?: Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use the descrypt algorithm for OS password hashing. While interactive, network-based logons are disabled, and attackers can use the other vulnerabilities within this report to obtain local shell access and access these hashes.
How severe is CVE-2019-13539?: CVE-2019-13539 has a CVSS 3.x base score of 7.0, rated high severity. It is exploitable over local access with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2019-13539 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (18th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2019-13539?: CVE-2019-13539 primarily affects Medtronic Valleylab Exchange Client. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2019-13539?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2019-13539 published?: CVE-2019-13539 was published on 2019-11-08 and last updated on 2026-06-17.

References

Affected products (3)

cpe:2.3:a:medtronic:valleylab_exchange_client:*:*:*:*:*:*:*:*
cpe:2.3:o:medtronic:valleylab_ft10_energy_platform_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:medtronic:valleylab_fx8_energy_platform_firmware:*:*:*:*:*:*:*:*

More vulnerabilities in Medtronic Valleylab Exchange Client

CVE-2019-13543 — Medium (CVSS 5.8): Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version…

All CVEs affecting Medtronic Valleylab Exchange Client →

Other CWE-326 (Inadequate Encryption Strength) vulnerabilities

CVE-2026-44523 — Critical (CVSS 10.0): Note Mark is an open-source note-taking application. Prior to 0.19.4, no minimum length or entropy is enforced on the…
CVE-2020-6966 — Critical (CVSS 10.0): In ApexPro Telemetry Server Versions 4.2 and prior, CARESCAPE Telemetry Server v4.2 & prior, Clinical Information…
CVE-2014-9199 — Critical (CVSS 10.0): The Clorius Controls Java web client before 01.00.0009g allows remote attackers to discover credentials by sniffing the…
CVE-2018-25272 — Critical (CVSS 9.8): ELBA5 5.8.0 contains a remote code execution vulnerability that allows attackers to obtain database credentials and…
CVE-2025-12478 — Critical (CVSS 9.8): Non-Compliant TLS Configuration.This issue affects BLU-IC2: through 1.19.5; BLU-IC4: through 1.19.5 .
CVE-2022-24116 — Critical (CVSS 9.8): Certain General Electric Renewable Energy products have inadequate encryption strength. This affects iNET and iNET II…

Browse all CWE-326 (Inadequate Encryption Strength) vulnerabilities →